Icahn Carl C Bausch Health Companies Inc. Transaction History
Icahn Carl C
- $9.83 Billion
- Q3 2024
A detailed history of Icahn Carl C transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Icahn Carl C holds 34,721,118 shares of BHC stock, worth $221 Million. This represents 2.88% of its overall portfolio holdings.
Number of Shares
34,721,118
Previous 34,721,118
-0.0%
Holding current value
$221 Million
Previous $242 Million
16.93%
% of portfolio
2.88%
Previous 2.24%
Shares
3 transactions
Others Institutions Holding BHC
# of Institutions
264Shares Held
256MCall Options Held
5.53MPut Options Held
16.6M-
Goldentree Asset Management LP New York, NY29.4MShares$187 Million21.8% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$168 Million14.7% of portfolio
-
National Bank Of Canada15.4MShares$98.1 Million0.17% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$82.7 Million0.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$74.3 Million0.0% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.3B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...